Tag: #Global Trends

On March 19, 2026, SK pharmteco, a leading Contract Development and Manufacturing Organization (CDMO), announced a strategic $100 million funding... Read more

On March 19, 2026, Seattle-based biopharmaceutical firm Atossa Therapeutics officially announced the addition of two key figures to its clinical... Read more

On March 20, 2026, Novartis announced an agreement with Synnovation Therapeutics to acquire Pikavation Therapeutics, the subsidiary holding the SNV4818... Read more

On March 20, 2026, Swiss pharmaceutical giant Roche officially announced the discontinuation of emugrobart, an experimental antibody aimed at treating... Read more

On March 20, 2026, Earendil Labs—a biotechnology startup with operations in both the U.S. and China—announced the successful closing of... Read more

March 20, 2026, marks a pivotal milestone for the Indian pharmaceutical industry as patents for Semaglutide (the active ingredient in... Read more

The upcoming patent expiry of semaglutide on March 20 in India is paving the way for a surge in affordable... Read more

The Argentine government has confirmed the termination of its membership in the World Health Organization (WHO). This move signifies a... Read more

SK pharmteco has announced the successful completion of a regulatory inspection conducted by the U.S. Food and Drug Administration (FDA)... Read more